Bullish case
$85 to $114
More likely if CorVel Corporation shows sustained 15%+ revenue growth from new client wins and CERIS group health expansion, margins improve, and the stock reclaims resistance above $70 with volume confirmation.
CorVel Corporation research snapshot
CRVL AI Stock Analysis
CRVL AI stock analysis currently reads CorVel Corporation as the only independent, publicly-traded claims management and healthcare cost containment company, serving self-insured employers, carriers, and TPAs. The page uses a scenario framework, not a certain price prediction. At the July 12, 2026 cutoff, the quoted price was $62.29, market capitalization was about $3.17 billion, and the main decision point was whether the stock has found a bottom after a 39% decline from its 52-week high. This is informational research and not investment advice.
Current price
$62.29
Market cap
$3.17 billion
AI score
53 / 100
Rating
Resilient niche business, cyclical valuation risk
Trend status
Downtrend from peak with recent base-building
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- B-level information richness. CorVel has decent public filings and some analyst coverage, but limited compared to mega-cap tech stocks. Most competitor data is private (TPAs owned by insurers).
- bias Check
- The AI bias risk is that limited public data on private competitors creates a false sense of competitive moat. The analysis separates verified financial data from qualitative assessments about market position.
- ai Confidence
- Medium data confidence
- investment Certainty
- Medium certainty because the page gives a framework, not a personalized buy or sell instruction. Key data gaps include full segment breakdown and private competitor financials.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | CorVel provides workers compensation claims management, medical bill review, case management, and cost containment services to employers, carriers, and TPAs. | Medium |
| Moat | The moat is built from 35+ years of industry relationships, proprietary Care platform, independence from insurance carriers, and the complexity of claims management workflows. | Medium |
| Management | Founder V. Gordon Clemons built the company from scratch. Recent CEO transition to Sarah Scott introduces execution risk. Insider ownership at 39% aligns interests but limits liquidity. | Medium-low |
| Financial trend | Revenue, net income, cash, equity, and market cap were verified mechanically and cross-validated across two sources with deviation under 1%. Consistent growth with strong margins. | Medium-high |
| Valuation | At 29x TTM PE and 34x P/FCF, valuation prices in continued mid-teens growth. Safety margin is thin if organic growth decelerates or margins compress. | Medium-low |
| Technical trend | Stock is down 39% from 52-week high in a downtrend with recent base-building around $55-65. Use live moving averages, support, resistance, momentum, volume, and invalidation levels before acting. | Medium |
| Risk level | The thesis can fail if workers comp claims cycle turns down, private competitors undercut on price, healthcare regulation shifts unfavorably, or CEO transition disrupts execution. | Medium-high |
| AI confidence | Medium data confidence for verified financials and qualitative mapping. Lower confidence for forward returns given thin analyst coverage and private competitor dynamics. | Medium |
| Investment certainty | Medium certainty because the page gives a framework, not a personalized buy or sell instruction. | Medium |
CRVL AI stock forecast
CRVL AI Stock Forecast Scenarios
The CRVL AI stock forecast uses scenario ranges around the $62.29 quote rather than a point target. The bullish case requires stronger evidence on organic growth and margin expansion; the base case assumes consistent execution; the bearish case assumes cyclical or competitive pressure becomes visible.
Base case
$65 to $80
More likely if fundamentals remain steady with 8-12% organic growth and the stock trades around current expectations while investors wait for the next filing or earnings update.
Bearish case
$35 to $47
More likely if these risk paths appear: workers comp claims volume declines, private competitors gain share, CEO transition disrupts execution, or insider selling accelerates, and technical support breaks below $55.
CRVL AI technical analysis
CRVL AI Technical Analysis
CRVL AI technical analysis starts from the $62.29 quote with observed average volume around 216,000 shares. Because this static page does not fetch request-time chart data, moving averages and live momentum should be confirmed in a charting tool before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $62.29 | Current quote used for this page as of the July 12, 2026 data cutoff. |
| Near support | $55.37 to $58.00 | Estimated from the recent 50-day low and price action. Treat as a planning zone, not a guaranteed floor. |
| Near resistance | $64.49 to $68.00 | Estimated from the recent 50-day high and nearby chart levels. A close above this zone would improve short-term momentum. |
| 50-day moving average | Requires live chart confirmation | Use current chart data before acting. The page does not fetch request-time market data. |
| 200-day moving average | Requires live chart confirmation | Long-term trend confirmation should be checked against a live chart or broker data. |
| Momentum | Downtrend from peak with recent base-building | The stock declined sharply from the $102 peak. Recent price action around $55-65 suggests a potential base, but trend reversal needs confirmation after the cutoff. |
| Volume | Below-average volume snapshot | The recent volume of ~108K was below the average of ~216K, suggesting reduced conviction in the current move. |
| Volatility | Medium monitoring priority | Use position sizing that can tolerate modest daily movement for this mid-cap ticker. |
| Invalidation | Close below $55.00 | A decisive close below the support zone would weaken the base-building narrative and suggest further downside toward the 52-week low of $44.83. |
CRVL AI trading strategy
CRVL AI Trading Strategy Framework
The CRVL AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, and fresh filings or news checks.
Trend-following setup
Wait for CRVL to hold above near support and push through the $64.49 resistance zone with volume that confirms buyer demand. A breakout above $68 would signal a stronger reversal attempt.
A close below the $55 support zone or a failed breakout should invalidate the setup.
Mean-reversion setup
If CRVL dips into the $55-58 support band without a thesis break, compare price action with the next earnings, insider trading patterns, and industry cycle indicators.
Do not average down without a predefined maximum loss and a fresh review of the business risk.
Fundamental monitor
Track the evidence that matters most for healthcare cost containment: organic revenue growth, margin trends, new client wins, competition from private TPAs, and insider buying or selling patterns.
Reduce confidence when price moves are driven by insider selling or industry headlines without matching financial evidence.
Investment research summary
Four-master Research Compression
Business essence
CorVel helps employers and insurers reduce healthcare costs related to workplace injuries, using technology-driven claims management, bill review, case management, and network services.
Moat
The moat comes from 35+ years of claims data, the proprietary Care platform, independence from insurance carriers, the complexity of regulatory workflows, and long-standing client relationships.
Munger risk inversion
The thesis can fail if workers comp claims volume declines in a soft labor market, private competitors (Sedgwick, Gallagher Bassett) out-invest in technology, healthcare regulation shifts, or the CEO transition disrupts the culture.
Management
The founder built a durable business over 35 years. The recent CEO transition from Michael Combs to Sarah Scott is the first leadership change in years and warrants monitoring for strategic continuity.
Industry trend
The shift toward self-insurance and AI-driven claims processing is a secular tailwind, but workers comp volume is tied to employment levels, which introduces cyclicality.
Valuation and margin of safety
At 29x TTM earnings with mid-teens growth, valuation is reasonable but not cheap. The market is pricing in continued execution, and the margin of safety is thin if growth disappoints or margins compress.
Source-backed data
CRVL Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CRVL price | $62.29 | Current quote snapshot cross-checked with user supplied market scan | July 12, 2026 |
| Market capitalization | $3.17 billion, verified as $62.29 x 50.91 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| Exchange | NasdaqGS | Public quote pages | July 12, 2026 |
| TTM revenue | $958.53 million, cross-validated within 0.02% deviation between StockAnalysis and CorVel IR | StockAnalysis, CorVel IR page | July 12, 2026 |
| TTM net income | $110.34 million, cross-validated within 0.02% deviation between StockAnalysis and CorVel IR | StockAnalysis, CorVel IR page | July 12, 2026 |
| Cash and equivalents | $233.07 million, cross-validated within 0.02% deviation. Zero debt per IR page. | StockAnalysis, CorVel IR page | July 12, 2026 |
Frequently Asked Questions
Use Pineify AI Stock PickerBuild an AI trading strategyRun an AI stock screenerRead the NVDA AI stock analysis
This CRVL AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of July 12, 2026, may be incomplete, and can be wrong if new filings, market prices, company events, or macro conditions change.
Related Tools
Trading Strategy Builder
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Try it
Stock Screener
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Try it
AI Stock Picker & Screener
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
Try it